71-Year-Old Cancer Patient Broke Trial Age Limits for a Chance at a Cure

After Mikhail Rubin learned his lethal blood disease had progressed, he decided that he wanted a stem-cell transplant through a clinical trial. But there was an obstacle: his age.

Read the entire article here on The Wall Street Journal.

Recent News & Updates